Thrombolysis, is a”best friend” of STEMI in non-covid times,.. but, definitely not during this deadly pandemic !
That’s how the title sounded to me, when I happened to read this paper from the reputed Circulation journal.
Even in the serene non-covid days, primary PCI rate in most countries is at best 10 % and thrombolysis* is the only savior in STEMI.(*with or without Pharmaco Invasvive )
It’s Covid times you know, can’t take science for a ride. Let us all take a pledge, in this deadly pandemic to increase pPCI rate to atleast 50% and ditch that dedicated, trustworthy , uncomplicated all weather friend !